Dr. Reddy's may join two other Indian pharmaceutical firms in bidding for Merck's huge generics operations. An analyst noted the sale of the European firm's generics business "could change the generics landscape forever."
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||